Komori
Japan Medical Dynamic Marketing (7600) · RiskMaterialised

Risk of declining per-case revenue in the United States

First written in FY2023-Q1. 1 of 1 entries say "Materialised", first in FY2023-Q1. Latest entry: FY2023-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Revenue decline due to lower per-case pricing in the United StatesA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023-Q1MaterialisedAnnual report

    「In the United States, case volumes increased compared with the same quarter of the previous year, when case volumes had increased as sales activities recovered with the expansion of COVID-19 vaccinations. However, due in part to the decline in revenue per case, sales to external customers declined 1.6% year on year in U.S. dollar terms, while increased 15.4% after translation into yen due to the weaker yen, to ¥2,093 million.」

    In the United States, the number of cases increased, but U.S.-dollar-denominated sales to external customers fell 1.6% year on year because of the impact of lower case pricing.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Japan Medical Dynamic Marketing yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of declining per-case revenue in the United States | Japan Medical Dynamic Marketing,INC. (7600) | Komori